Asia-Pacific COVID-19 Diagnostics Market
Asia-Pacific COVID-19 Diagnostics Market Size, Share & Trends Analysis Report by Type (Instruments, Reagents & Kits, and Laboratory Testing Services), by Technology Type (PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test), by Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Blood, Urine, Saliva, and Others), and by End-User (Laboratories, Hospitals, Diagnostic Centers & Clinics, and Research Institutes) and Forecast, 2020-2026 Update Available - Forecast 2024-2030
Asia-Pacific COVID-19 diagnostics market is estimated to see a decline in CAGR of 22.2% during the forecast period. Asia-Pacific COVID-19 diagnostics market has been growing at a rapid pace owing to the significantly growing screening test in the emerging economies such as India, China, Japan, and the rest of Asia-Pacific countries. China was the first economy that was severely hit by COVID-19 as the country was the epicenter of the COVID-19. The market in the region is mainly growing due to the introduction of various advanced and early detection diagnostics kits in the region. The significant number of hospitals providing advanced and rapid diagnostics further contribute to the market share in the region. Through this increased testing services, nursing homes will be able to augment their response against the COVID-19 and aid in preventing the spread of SARS-CoV-2.
Visit for Global COVID-19 Diagnostics Market Report at: https://www.omrglobal.com/industry-reports/covid-19-diagnostics-market
Asia-Pacific COVID-19 diagnostics market is segmented based on technology type, end-use, sample type, and product type. By technology type, the market is further segmented into PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test. By end-use, the COVID-19 diagnostic market is divided into laboratories, hospitals, diagnostic centers & clinics, and research institutes. By product type, the market is further segmented into instruments, reagents & kits, and laboratory testing services. By Sample type, the market is divided into oropharyngeal & nasopharyngeal swabs, blood, urine, saliva, and others.
Asia-Pacific COVID-19 diagnostics market is segmented based on countries, China, India, Japan, and the Rest of Asia-Pacific. China held the largest market value in the Asia-Pacific COVID-19 diagnostics market. China was the first economy that was severely hit by COVID-19 as the country was the epicenter of the COVID-19. The market in the country is mainly dominating due to the introduction of various advanced and early detection diagnostics kits. India has the second-largest share in the Asia-Pacific COVID-19 diagnostics market. The market is backed by a significant number of samples tested in the country.
The companies which are contributing to the growth of the Asia-Pacific COVID-19 diagnostics market include BGI Group, Mylab Discovery Solutions Pvt Ltd., Sansure Biotech Inc., Seegene Inc., and ADT Biotech Sdn Bhd. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market. For instance, in March 2020, India-based Mylab Discovery became the first company in the country to receive approval for its COVID-19 diagnostic test kits, called RT-PCR tests. The testing kit has been commercially approved by the Central Drugs Standard Control Organization (CDSCO).
Research Methodology
The market study of the Asia-Pacific COVID-19 diagnostics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
- Financial reports of companies involved in the market.
- Whitepapers, research-papers, and news blogs.
- Company websites and their product catalog.
The report provides an in-depth analysis of market size, various services offered by the players, and market opportunity. The report will serve as a source for 360-degree analysis of the market delivering insights for making better business decisions.
Market Segmentation
- Asia-Pacific COVID-19 Diagnostics Market Research and Analysis by Type
- Asia-Pacific COVID-19 Diagnostics Market Research and Analysis by Technology Type
- Asia-Pacific COVID-19 Diagnostics Market Research and Analysis by Sample Type
- Asia-Pacific COVID-19 Diagnostics Market Research and Analysis by End-Users
The Report Covers
- Comprehensive research methodology of the Asia-Pacific COVID-19 diagnostics market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Asia-Pacific COVID-19 diagnostics market.
- Insights about market determinants which are stimulating the Asia-Pacific COVID-19 diagnostics market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Asia-Pacific COVID-19 Diagnostics Market by Type
5.1.1. Instruments
5.1.2. Reagents & Kits
5.1.3. Laboratory Testing Services
5.2. Asia-Pacific COVID-19 Diagnostics Market by Technology Type
5.2.1. PCR Test
5.2.2. Antigen Test
5.2.2.1. Chromatographic Immunoassay
5.2.2.2. Fluorescent Immunoassay
5.2.2.3. Chemiluminescent Immunoassay
5.2.3. Serology Test
5.2.3.1. Enzyme-Linked Immunosorbent Assay (ELISA)
5.2.3.2. Neutralization
5.2.3.3. Chemiluminescent Immunoassay
5.2.4. Rapid/ PoC Test
5.3. Asia-Pacific COVID-19 Diagnostics Market by Sample Type
5.3.1. Oropharyngeal & Nasopharyngeal Swabs
5.3.2. Blood
5.3.3. Urine
5.3.4. Saliva
5.3.5. Others (Sperm)
5.4. Asia-Pacific COVID-19 Diagnostics Market by End-User
5.4.1. Laboratories
5.4.2. Hospitals
5.4.3. Diagnostic Centers & Clinics
5.4.4. Research Institutes
6. Regional Analysis
6.1. China
6.2. India
6.3. Japan
6.4. Rest of Asia-Pacific
7. Company Profiles
7.1. ADT BiotechSdnBhd
7.2. BGI Group
7.3. CPC Diagnostics Pvt. Ltd.
7.4. Guangzhou Wondfo Biotech Co., Ltd.
7.5. J Mitra & Co. Pvt Ltd.
7.6. Mylab Discovery Solutions Pvt Ltd.
7.7. Sansure Biotech Inc.
7.8. Seegene Inc.
7.9. Sysmex Corp.
7.10. Veredus Laboratories Pte Ltd.
1. ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
2. ASIA-PACIFIC COVID-19 DIAGNOSTICS INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
3. ASIA-PACIFIC COVID-19 DIAGNOSTICS REAGENTS & KITS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
4. ASIA-PACIFIC COVID-19 DIAGNOSTICS LABORATORY TESTING SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
5. ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY TYPE, 2019-2026 ($ MILLION)
6. ASIA-PACIFIC COVID-19 DIAGNOSTICS PCR TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
7. ASIA-PACIFIC COVID-19 DIAGNOSTICS ANTIGEN TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
8. ASIA-PACIFIC COVID-19 DIAGNOSTICS SEROLOGY TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
9. ASIA-PACIFIC COVID-19 DIAGNOSTICS RAPID/POC TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
10. ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2019-2026 ($ MILLION)
11. ASIA-PACIFIC COVID-19 DIAGNOSTICS THROUGH OROPHARYNGEAL & NASOPHARYNGEAL SWABS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
12. ASIA-PACIFIC COVID-19 DIAGNOSTICS THROUGH BLOOD MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
13. ASIA-PACIFIC COVID-19 DIAGNOSTICS THROUGH URINE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
14. ASIA-PACIFIC COVID-19 DIAGNOSTICS THROUGH SALIVA MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
15. ASIA-PACIFIC COVID-19 DIAGNOSTICS THROUGH OTHER SAMPLES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
16. ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2019-2026 ($ MILLION)
17. ASIA-PACIFIC COVID-19 DIAGNOSTICS IN HOSPITALS SWABS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
18. ASIA-PACIFIC COVID-19 DIAGNOSTICS IN DIAGNOSTIC CENTERS AND URGENT CARE CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
19. ASIA-PACIFIC COVID-19 DIAGNOSTICS IN RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
20. ASIA-PACIFIC COVID-19 DIAGNOSTICS IN LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
21. ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
22. CHINA COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
23. CHINA COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY TYPE, 2019-2026 ($ MILLION)
24. CHINA COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2019-2026 ($ MILLION)
25. CHINA COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2019-2026 ($ MILLION)
26. INDIA COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
27. INDIA COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY TYPE, 2019-2026 ($ MILLION)
28. INDIA COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2019-2026 ($ MILLION)
29. INDIA COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2019-2026 ($ MILLION)
30. JAPAN COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
31. JAPAN COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY TYPE, 2019-2026 ($ MILLION)
32. JAPAN COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2019-2026 ($ MILLION)
33. JAPAN COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2019-2026 ($ MILLION)
34. REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
35. REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY TYPE, 2019-2026 ($ MILLION)
36. REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2019-2026 ($ MILLION)
37. REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2019-2026 ($ MILLION)
1. ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET SIZE, 2019-2026 ($ MILLION)
2. ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)
3. ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET SHARE BY TYPE, 2019 VS 2026 (%)
4. ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET SHARE BY TECHNOLOGY TYPE, 2019 VS 2026 (%)
5. ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET SHARE BY SAMPLE TYPE, 2019 VS 2026 (%)
6. ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET SHARE BY END-USERS, 2019 VS 2026 (%)
7. CHINA COVID-19 DIAGNOSTICS MARKET SIZE, 2019-2026 ($ MILLION)
8. JAPAN COVID-19 DIAGNOSTICS MARKET SIZE, 2019-2026 ($ MILLION)
9. INDIA COVID-19 DIAGNOSTICS MARKET SIZE, 2019-2026 ($ MILLION)
10. REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET SIZE, 2019-2026 ($ MILLION)
